Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian Treatment Outcome Study (ATOS)

Addictive Behaviors

Volumn 32, Issue 9, 2007, Pages 1897-1906

  Darke, Shane ^a   Ross, Joanne ^a   Mills, Katherine L ^a   Williamson, Anna ^a   Havard, Alys ^a   Teesson, Maree ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Abstinence; ATOS; Heroin; Longitudinal; Treatment

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; METHADONE;

ADULT; ARTICLE; CONTROLLED STUDY; CRIME; DRUG DETOXIFICATION; DRUG USE; FEMALE; FOLLOW UP; HEROIN DEPENDENCE; HUMAN; LONG TERM MEMORY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PREDICTOR VARIABLE; SEX DIFFERENCE; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; AUSTRALIA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEROIN DEPENDENCE; HUMANS; MALE; MIDDLE AGED; PREVALENCE;

EID: 34447109071     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2007.01.014     Document Type: Article

References (25)

1. Agresti A. Categorical data analysis. (2nd edition). (2002), John Wiley & Sons, New Jersey
2. Ball J.C., and Ross A. The effectiveness of methadone treatment. Patients, programs, services, and outcome (1991), Springer-Verlag, New York
3. Cacciola J.S., Alterman A.I., Rutherford M.J., McKay J.R., and Mulvaney F.D. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug and Alcohol Dependence 61 (2001) 271-280
4. Darke S., Hall W., Heather N., Wodak A., and Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opioid users: The Opiate Treatment Index. British Journal of Addiction 87 (1992) 593-602
5. Darke S., Hall W., Kaye S., Ross J., and Duflou J. Hair morphine concentrations of fatal heroin overdose cases and living heroin users. Addiction 97 (2002) 977-984
6. Darke S., Ross J., Teesson M., Ali R., Cooke R., Ritter A., et al. Factors associated with 12 months continuous heroin abstinence: Findings from the Australian Treatment Outcome Study (ATOS). Journal of Substance Abuse Treatment 28 (2005) 255-263
7. Darke S., Williamson A., Ross J., and Teesson M. Reductions in heroin use are not associated with increases in other drug use: Two year findings from the Australian Treatment Outcome Study. Drug and Alcohol Dependence 84 (2006) 201-205
8. Flynn P.M., Joe G.W., Broome K.M., Simpson D.D., and Brown B.S. Recovery from opioid addiction in DATOS. Journal of Substance Abuse Treatment 25 (2003) 177-186
9. Fugelstad A., Ahlner J., Brandt L., Ceder G., Eksborg S., Rajs J., et al. Use of morphine and 6-monoacetylmorphine in blood for the evaluation of possible risk factors for sudden death in 192 heroin users. Addiction 98 (2003) 463-470
10. Gossop M., Marsden J., Stewart D., and Treacy S. Change and stability of change after treatment of drug misuse. 2 year outcomes from the National Treatment Outcome Research Study (UK). Addictive Behaviors 27 (2002) 155-166
11. Hser Y., Grella C.E., Hsieh S., Anglin M.D., and Brown B. Prior treatment experience related to process and outcomes in DATOS. Drug and Alcohol Dependence 57 (1999) 137-150
12. Hser Y., Hoffman V., Grella C., and Anglin M.D. A 33-year follow-up of narcotic addicts. Archives of General Psychiatry 58 (2001) 503-508
13. Hubbard R.L., Craddock S.G., Flynn P.M., Anderson J., and Etheridge R.M. Overview of one year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors 11 (1997) 261-278
14. Joe G.W., Simpson D.D., and Broome K.M. Retention and patient engagement in models for different treatment modalities in DATOS. Drug and Alcohol Dependence 57 (1999) 113-125
15. Kosten T.R., Rounsaville B.J., and Kleber H.D. A 2.5 year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. Archives of General Psychiatry 43 (1986) 733-738
16. Robins L.N., Helzer J.E., Croughan J., and Ratcliff K.S. National Institute of Mental Health Diagnostic interview schedule: Its history, characteristics, and validity. Archives of General Psychiatry 38 (1981) 381-389
17. Ross J., Teesson M., Darke S., Lynskey M., Ali R., Ritter A., et al. Short-term outcomes for the treatment of heroin dependence: Findings from Australian Treatment Outcome Study (ATOS). Addictive Disorders and their Treatment 5 (2006) 133-144
18. Rounsaville B.J., Kosten T.R., Weissman M.M., and Kleber H.D. Prognostic significance of psychopathology in treated opiate addicts. Archives of General Psychiatry 43 (1986) 739-745
19. Sheehan M., Oppenheimer E., and Taylor C. Opiate users and the first years after treatment: Outcome analysis of the proportion of follow-up time spent in abstinence. Addiction 88 (1993) 1679-1689
20. Simpson D.D., and Marsh K.L. Relapse and recovery among opioid addicts 12 years after treatment. In: Tims F.M., and Leukefeld C.G. (Eds). Relapse and Recovery in Drug Abuse. NIDA Research Monograph no. 72. (1986), Department of Health and Human Services, Maryland
21. SPSS inc. SPSS for Windows, 14.0 (2005), SPSS Inc., Chicago
22. Tagliaro F., Debattisti Z., Smith F.P., and Marigo M. Death from heroin overdose: Findings from hair analysis. Lancet 351 (1998) 1923-1925
23. Teesson M., Ross J., Darke S., Lynskey M., Ali R., Cooke R., et al. The Australian Treatment Outcome Study (ATOS): 1 year follow-up results. Drug and Alcohol Dependence 83 (2006) 174-180
24. Ware J.E., Kosinski M., and Keller S.D. A 12-item short-form health survey: Construction of scales, and preliminary tests of reliability and validity. Medical Care 34 (1996) 220-233
25. World Health Organization. Composite international diagnostic interview (version 1.1) (1993), World Health Organization, Vienna